Have your own idea? Try our Stock Screener
Belgian (BEL20) Biotech Industry Analysis
UpdatedApr 26, 2025
DataAggregated Company Financials
Companies3
- 7D2.2%
- 3M-14.2%
- 1Y53.3%
- YTDn/a
In the last week, the Biotech industry is up 1.4%, with argenx up 2.2%. In the same time, Celyad Oncology was down 11%. This means that the industry has gained 53% over the past year. Earnings are forecast to grow by 29% annually.
Industry Valuation and Performance
Has the Belgian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 26 Apr 2025 | €32.8b | €2.0b | €727.4m | 43.6x | 45x | 16.2x |
| Mon, 24 Mar 2025 | €34.7b | €2.1b | €761.2m | 45.1x | 45.6x | 16.4x |
| Wed, 19 Feb 2025 | €37.4b | €1.9b | -€47,364,254.50 | n/a | -788.6x | 20x |
| Fri, 17 Jan 2025 | €38.7b | €1.9b | -€47,932,385.80 | n/a | -808.3x | 20.4x |
| Sun, 15 Dec 2024 | €35.1b | €1.9b | -€47,215,170.40 | n/a | -743.9x | 18.9x |
| Tue, 12 Nov 2024 | €33.5b | €1.8b | -€46,643,009.80 | n/a | -717.9x | 18.2x |
| Thu, 10 Oct 2024 | €28.3b | €1.6b | -€195,636,199.00 | n/a | -144.9x | 18.1x |
| Sat, 07 Sep 2024 | €29.2b | €1.5b | -€193,455,755.50 | n/a | -150.9x | 19x |
| Mon, 05 Aug 2024 | €27.3b | €1.6b | -€196,398,323.50 | n/a | -138.8x | 17.4x |
| Wed, 03 Jul 2024 | €24.0b | €1.4b | -€314,188,137.40 | n/a | -76.5x | 17.2x |
| Fri, 31 May 2024 | €20.1b | €1.4b | -€311,767,683.30 | n/a | -64.4x | 14.6x |
| Sun, 28 Apr 2024 | €20.8b | €1.2b | -€285,141,544.40 | n/a | -72.9x | 17x |
| Tue, 26 Mar 2024 | €21.8b | €1.2b | -€303,712,897.80 | n/a | -71.6x | 18x |
| Thu, 22 Feb 2024 | €21.9b | €990.3m | -€248,219,127.40 | n/a | -88.4x | 22.2x |
| Sat, 20 Jan 2024 | €19.7b | €1.0b | -€287,777,157.00 | n/a | -68.4x | 18.9x |
| Mon, 18 Dec 2023 | €25.2b | €1.0b | -€287,712,649.00 | n/a | -87.5x | 24.2x |
| Wed, 15 Nov 2023 | €27.1b | €1.0b | -€288,634,389.00 | n/a | -93.8x | 25.9x |
| Fri, 13 Oct 2023 | €28.3b | €885.6m | -€454,276,849.00 | n/a | -62.2x | 31.9x |
| Sun, 10 Sep 2023 | €28.5b | €869.7m | -€452,299,269.00 | n/a | -63x | 32.8x |
| Tue, 08 Aug 2023 | €26.0b | €838.0m | -€450,543,296.00 | n/a | -57.7x | 31x |
| Thu, 06 Jul 2023 | €19.7b | €668.1m | -€561,244,555.00 | n/a | -35x | 29.4x |
| Sat, 03 Jun 2023 | €20.7b | €676.1m | -€567,726,193.00 | n/a | -36.5x | 30.6x |
| Mon, 01 May 2023 | €19.5b | €452.8m | -€724,874,485.00 | n/a | -26.9x | 43.1x |
| Wed, 29 Mar 2023 | €18.9b | €459.9m | -€735,952,964.00 | n/a | -25.7x | 41.1x |
| Fri, 24 Feb 2023 | €19.4b | €317.4m | -€921,949,531.00 | n/a | -21.1x | 61.2x |
| Sun, 22 Jan 2023 | €19.9b | €309.9m | -€894,777,995.00 | n/a | -22.2x | 64.2x |
| Tue, 20 Dec 2022 | €20.0b | €316.3m | -€913,838,614.00 | n/a | -21.9x | 63.2x |
| Thu, 17 Nov 2022 | €19.9b | €322.6m | -€932,804,874.00 | n/a | -21.3x | 61.6x |
| Sat, 15 Oct 2022 | €20.3b | €194.3m | -€991,466,668.00 | n/a | -20.5x | 104.7x |
| Mon, 12 Sep 2022 | €21.8b | €170.1m | -€963,124,300.00 | n/a | -22.7x | 128.3x |
| Wed, 10 Aug 2022 | €20.5b | €165.8m | -€943,243,409.00 | n/a | -21.8x | 123.8x |
| Fri, 08 Jul 2022 | €20.2b | €397.8m | -€641,161,219.00 | n/a | -31.5x | 50.7x |
| Sun, 05 Jun 2022 | €16.3b | €377.4m | -€609,542,764.00 | n/a | -26.7x | 43.1x |
| Tue, 03 May 2022 | €15.5b | €524.0m | -€442,702,731.00 | n/a | -34.9x | 29.5x |
Price to Earnings Ratio
-34.9x
Current Industry PE
- There are only 3 companies in the Belgian Biotechnology industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Biotechnology industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 57% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Belgian Biotech compare with similar industries?
| BE Market | 1.79% | |
| Healthcare | 5.56% | |
| Biotech | 2.20% | |
| Biotech | 2.20% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ARGX argenx | €535.80 | 2.2% +€708.3m | 53.4% | PE44.7x | |
| ALEMS European Medical Solutions | €5.50 | 1.9% +€427.4k | -13.2% | PE42.6x |